Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis

BMC Gastroenterology

Volumn 1, Issue , 2001, Pages

  Quallich, Leonard G ^a   Greenson, Joel ^a   Haftel, Hilary M ^a   Fontana, Robert J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; CETIRIZINE; CORTICOSTEROID; GADOLINIUM; HYDROXYCHLOROQUINE; IRON; NAPROXEN; OXCARBAZEPINE; PHENYTOIN; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID; SULFANILAMIDE;

ABDOMINAL PAIN; ADULT; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; CROHN DISEASE; DIAGNOSIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG ERUPTION; DRUG THERAPY; ENTERITIS; EOSINOPHILIA; ERYTHEMA; FATIGUE; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAND MAL SEIZURE; GRANULOMA; GRANULOMATOSIS; HUMAN; NIGHT SWEAT; PRESCRIPTION; REVIEW; RHEUMATOID ARTHRITIS; SCLERA DISEASE; SEIZURE; SKIN EDEMA; TOXIC HEPATITIS;

ADULT; ADVERSE EFFECTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHEMICALLY INDUCED; CROHN DISEASE; DIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY; ENTERITIS; EOSINOPHILIA; FEMALE; GRANULOMA; HEPATITIS, TOXIC; HUMANS; SEIZURES; SULFASALAZINE;

EID: 2942563937     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-1-8     Document Type: Review

References (45)

1. Peppercorn MA: Sulphasalazine pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med 1984, 3:377-386
2. Das KM: Sulphasalazine therapy in inflammatory bowel disease. Gastroenterol Clin North Amer 1989, 18:1-20
3. Dick AP, Grayson MJ, Carpenter RG, Petrie A: Controlled trial of sulfasalazine in the treatment of ulcerative colitis. Gut 1964, 5:437-432
4. Dougados M, Van der Linden S, Leirisalo-Repo M, et al: Sulfasalazine in the treatment of sponyloarthropathy: a randomized, multi-center, double-blinded, placebo-controlled study. Arthritis Rheum 1995, 38:618-627
5. Pinals RS, Kaplan SB, Lawson JG, Hepburn B: Sulfasalazine in rheumatoid arthritis. Arthritis Rheum 1986, 29:1427-1434
6. Imundo LF, Jacobs JC: Sulfasalazine therapy for juvenile rheumatoid arthritis. J Rheumatol 1996, 23:360-366
7. Amos RS: The history of the use of sulphasalazine in rheumatology. Br J Rheumatol 1995, 34:2-6
8. Van Riel PLCM, Van Gestel AM, Van De Putte LBA: Long-term usage and side effect profile of sulphasalazine in rheumatoid arthritis. Br J Rheumatol 1995, 34:40-42
9. Amos RS, Pullar TT, Bax DE, et al: Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) 1986, 293:420-423
10. Situnayake RD, Grindulis KA, McConkey B: Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis 1987, 46:177-183
11. Nakajima H, Munakata A, Yoshida : Adverse effects of sulfasalazine and the treatment of ulcerative colitis with mesalazine. J Gastroenterol 1995, 30:115-117
12. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines: Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996, 39:723-731
13. Laasila K, Leirisalo-Repo M: Side effects of sulphasalazine in patients with rheumatic diseases of inflammatory bowel disease. Scand J Rheumatol 1994, 23:338-340
14. Watkinson G: Sulphasalazine: A review of 40 years' experience. Drugs 1986, 32:1-11
15. Losek JD, Werlin SL: Sulfasalazine hepatotoxicity. Am J Dis Child 1981, 135:1071-1072
16. Dujovne C, Chan C, Zimmerman J: Sulfonamide hepatic injury. N Engl J Med 1967, 277:785-788
17. Brooks H, Taylor H, Nichol F: The three week sulphasalazine syndrome. Clin Rheum 1992, 11:566-568
18. Rafoth R: Systemic granulomatous reaction to salicylazosulfapyridine (Azulfidine) in a patient with Crohn's disease. Dig Diseases 1974, 19:465-469
19. Singer DR, Simpson JG, Catto GR, Johnston AW: Drug hypersensitivity causing granulomatous interstitial hepatitis. Am J Kid Dis 1988, 11:357-359
20. Bramlet DA, Posalaky Z, Olson R: Granulomatous hepatitis as a manifestation of quinidine hypersensitivity. Arch Intern Med 1980, 140:395-397
21. Takami A, Nakao S, Miyamori H, et al: Adult Onset Still's disease with submassive hepatic necrosis. Internal Medicine 1995, 34:89-91
22. Fich A, Schwartz J, Braverman D, Zifroni A, Rachmilewitz D: Sulfasalazine hepatotoxicity. Am J Gastroenterol 1984, 79:401-402
23. Namias A, Bhalotra R, Donowitz M: Reversible sulfasalazine-induced granulomatous hepatitis. J Clin Gastroenterol 1981, 3:193-198
24. Callen J, Soderstrom : Granulomatous hepatitis associated with salicylazosulfapyridine therapy. S Med Journal 1978, 71:1159-1160
25. Huang JL, Hung I, Chen LC, Lee WY, Hsueh C, Hsieh KH: Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin. Clin Rheumatol 1998, 17:349-352
26. Rubin R: Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am J Gastroenterol 1994, 89:789-791
27. Marinos G, Riley J, Painter D, McCaughan G: Sulfasalazine-induced fulminant hepatic failure. J Clin Gastroenterol 1992, 14:132-135
28. Ribe J, Benkov K, Thung S, Shen S, LeLeiko N: Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine. Am J Gastroenterol 1986, 81:205-208
29. Kanner RS, Tedesco FJ, Kalser MH: Azulfidine (sulfasalazine) induced hepatic injury. Am J Dig Dis 1978, 23:956-8
30. Gulley RM, Mirza A, Kelley CE: Hepatotoxicity of salicylazosulfapyridine: A case report and review of the literature. Am J Gastroenterol 1979, 72:561-564
31. Smith MD, Gibson GE, Rowland R: Combined hepatotoxicity and neurotoxicity following sulfasalazine administration. Aust N Z J Med 1982, 12:76-80
32. Shear NH, Spielberg SP, Grany DM, et al: Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986, 105:179-184
33. Rieder MJ, Shear NH, Kanee A, et al: Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharm Ther 1991, 49:13-17
34. Keisu M, Ekman E: Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Eur J Clin Pharmacol 1992, 43:215-218
35. Maddocks JL, Slater DN: Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulfasalazine. J R Soc Med 1980, 73:587-588
36. Roth DA, Lindert M: A fatal case of Azulfidine-induced agranulocytosis. Gastroenterology 1959, 37:787-789
37. Jacobson IM, Kelsey PB, Blyden GT, et al: Sulfasalazine induced agranulocytosis. Am J Gastroenterol 1985, 80:118-121
38. Jick H, Myers MW, Dean AD: The risk of sulfasalazine and mesalazine-associated blood disorders. Pharmacotherapy 1995, 15:176-181
39. Kuipers E, Vellenga E, Joost T, Hazenberg B: Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor. J Rheumatol 1992, 19:621-622
40. Roddie P, Dorrance H, Cook M, Rainey J: Treatment of sulphasalazine-induced agranulocytosis with granulocyte macrophage-colony stimulating factor. Aliment Pharm Ther 1995, 9:711-712
41. Senturk T, Aydintug A, Duzgun N, Tokgoz G: Seizures and hepatotoxicity following sulphasalazine administration. Rheumatol Int 1997, 17:75-77
42. Hill ME, Gordon C, Situnayake RD, Heath DA: Sulfasalazine induced seizures and dysphagia. J Rheumatol 1994, 21:748-749
43. Krumholz A, Stern BJ, Stern EG: Clinical implications of seizures in neurosarcoidosis. Arch Neurol 1991, 48:842-844
44. Pentland B, Mitchell JD, Cull RE, Ford MJ: Central nervous system sarcoidosis. QJM 1985, 56:457-465
45. Wolkenstein P, Charue D, Laurent P, et al: Metabolic predisposition to cutaneous adverse drug reactions: Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Derm 1995, 131:544-551